OncoImmunology
Volume 5, 2016 - Issue 6
Open access
2,889
Views
29
CrossRef citations to date
0
Altmetric
Original Research
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
Ming ChengDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Brian H. SantichDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Hong XuDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Mahiuddin AhmedDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Morgan HuseImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
& Nai-Kong V. CheungDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
Article: e1168557
|
Received 18 Feb 2016, Accepted 14 Mar 2016, Published online: 15 Jun 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.